Loading clinical trials...
Loading clinical trials...
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Conditions
Interventions
Doxorubicin Hydrochloride
Irinotecan Hydrochloride
+8 more
Locations
187
United States
Children's Hospital of Alabama
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of South Alabama
Mobile, Alabama, United States
Phoenix Childrens Hospital
Phoenix, Arizona, United States
University of Arizona Health Sciences Center
Tucson, Arizona, United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Start Date
June 1, 2006
Primary Completion Date
December 1, 2015
Last Updated
July 21, 2017
NCT06863311
NCT07123090
NCT06349642
NCT07300241
NCT05433142
NCT07227415
Lead Sponsor
Children's Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions